Polyplexus

🌎💡Wellcome Trust is now accepting applications for its Climate Impacts Awards, a unique opportunity for transdisciplinary teams to drive policy change and make the health effects of climate change visible. This award supports research projects that aim to generate context-specific evidence on the health impacts of climate change and influence policy outcomes. Application Deadline: April 30, 2025. Focus Areas: Proposals should target specific policy opportunities with a clear theory of change, focusing on communities most impacted by climate change in both high-income and low- or middle-income countries. Learn More & Apply: https://lnkd.in/gzWQy2z5 #ClimateImpactsAwards #WellcomeTrust #ClimateAction #HealthResearch #GrantFunding #TransdisciplinaryResearch #PolicyChange #Sustainability

AI is revolutionizing climate prediction, potentially saving lives by providing faster, more accurate forecasts of extreme weather events. 🌡️ 👏 In a recent TEDx Planet Action talk, Mike Pritchard, Director of Climate Simulation Research at NVIDIA and professor at UC Irvine, showcased advancements in AI-powered Earth system modeling. 💡 Key highlights from Pritchard's presentation include: - Unprecedented Speed: AI-driven simulations can now be performed thousands of times faster than traditional physics-based models. - Enhanced Efficiency: These new models are significantly more efficient, allowing for high-fidelity studies of rare and extreme weather events. - Democratizing Access: AI climate models are becoming more user-friendly, making climate science more accessible to a broader audience. - High-Resolution Predictions: NVIDIA's Earth-2 platform, featuring the CorrDiff generative AI weather model, enables kilometer-scale forecasts of wind, temperature, and precipitation. Pritchard's work at the Computational Clouds and Climate Lab focuses on advancing cloud-resolving weather and climate simulations using physics-informed machine learning. His approach combines next-gen global atmospheric simulation algorithms, theoretical climate dynamics, machine learning, and high-performance computing. This has far-reaching implications for climate research, disaster preparedness, and our understanding of Earth's systems. As the world grapples with increasing extreme weather events due to climate change, AI-powered models offer a tool for more accurate predictions and better-informed decision-making. Listen to the full talk below. 👇 #ClimateScience #AI #WeatherPrediction #NVIDIA #TED #ExtremeWeather

Stem Cell Therapy Repairs Damaged Corneas and Improves Sight 👀 🔬 Researchers at Mass. Eye and Ear have developed a promising stem cell therapy for severe corneal injuries that were previously untreatable. In a Phase I/II clinical trial, the innovative procedure, involving the transplantation of stem cells harvested from the patient's healthy eye, successfully restored the surface of damaged corneas in 92% of patients, with 77% achieving full restoration. All participants experienced improvements in visual acuity. 👏 This autologous limbal epithelial cell (CALEC) transplant offers hope for those suffering from limbal stem cell deficiency and could potentially become a new standard of care. This marks the first successful application of cell therapy of its kind in the U.S. for corneal blindness. Kudos to Ula V. Jurkunas and the entire team for this significant advancement! #stemcelltherapy #regenerativemedicine #ophthalmology #cornea #vision #healthcare #innovation #research #masseyeandear

🚀 Firefly Aerospace's Blue Ghost lander, carrying NASA science & tech, successfully touched down on the Moon. 🌕 This marks a milestone in NASA - National Aeronautics and Space Administration's CLPS initiative and the Artemis campaign for future lunar endeavors and long-term human presence. The mission's 10 NASA instruments will spend the next 14 Earth days gathering critical data – from subsurface drilling tech to radiation-tolerant computing – which will benefit future missions to the Moon and Mars. A focus will be placed on capturing imagery of the lunar sunset and how lunar dust reacts to solar influences. This collaboration demonstrates the power of partnerships in driving innovation and expanding our understanding of space. #MoonLanding #SpaceExploration #NASA #FireflyAerospace #Artemis #CLPS #Science #Technology #Lunar

👏 Advanced Research Projects Agency for Health (ARPA-H) Dash finalist Anuradha Lingappa & Prosetta Biosciences Inc were invited by The Royal Society to present groundbreaking cancer drug discovery research! Join the seminar on March 5, 9 AM PST. 📆 #CancerResearch #BiotechInnovation #DrugDiscovery

🎓🔬A new analysis reveals a critical perspective on the state of American research universities, suggesting that many institutions may struggle to remain competitive amid shifting federal spending priorities and a shrinking pool of students. Instead of relying on simplistic "ranking" systems, a framework was proposed that incorporates the diverse goals, student populations, and financial models that shape these vital institutions. This approach paints a clearer picture of the strengths and weaknesses within the U.S. research enterprise. The big question: Can the U.S. afford to let the number of research universities dramatically shrink? This article prompts a conversation about the future of research and development in the United States. Read more about this new method for comparing research universities and assessing the health of the research enterprise. #HigherEducation #ResearchUniversities #Innovation #STEM #EducationPolicy #FutureofResearch #EconomicGrowth #Science #Technology #Academia

Exciting news from Advanced Research Projects Agency for Health (ARPA-H) Dash finalist Anuradha Lingappa with Prosetta Biosciences Inc. Their groundbreaking cancer drug research has caught the attention of The Royal Society.👏 Dr. Anuradha Lingappa and her father will present their innovative approach to drug discovery, including remarkable results against diverse cancers and a recent successful study on metastatic triple-negative breast cancer. 🗓️ Join their seminar on March 5th at 9 AM PST to learn about this game-changing cancer treatment. 👉 Register here: https://lnkd.in/gHw-sgRq #CancerResearch #Oncology #ARPAH #InnovativeMedicine

🧬 Could CRISPR technology offer new hope for Down syndrome treatment? A recent study suggests the possibility of "snipping away" extra chromosomes using CRISPR, potentially revolutionizing how we approach this condition. This is still early research, but the implications are enormous! Imagine a future where the effects of Down syndrome could be mitigated through gene editing. #CRISPR #DownSyndrome #GeneEditing #MedicalBreakthrough #Research #Genetics #Science

🎉 Thank you to Hannah Green of Boston Business Journal for sharing the thrilling announcement of Cellino's first autonomous iPSC Foundry at Massachusetts General Hospital, in collaboration with the amazing team at Mass General Brigham's Cell and Gene Therapy Institute! 💡 Why does this matter? Today, autologous cell and tissue therapies aren’t scalable for large populations, largely because manufacturing bottlenecks have held the industry back. But Cellino’s optical bioprocess changes the game. With our scientists in the loop, not in the lab, we’re making personalized regenerative medicine more scalable, affordable, and accessible. This is the future of healthcare, and it starts today! 📢 Read the exclusive interview with our CEO & Co-Founder Nabiha Saklayen at https://lnkd.in/ewm8ZvtH #RegenerativeMedicine #Biomanufacturing #AI #CellTherapies #PatientAccess #YourCellsYourCure

🎉 Thrilled to see Cellino, the winner from our Advanced Research Projects Agency for Health (ARPA-H) Dash, take another giant leap forward! Cellino is officially launching the U.S.'s first Nebula-Powered iPSC Foundry for scalable autologous biomanufacturing at Massachusetts General Hospital. This collaboration with Mass General Brigham's Gene and Cell Therapy Institute Institute marks a step towards decentralized, patient-specific cell therapy production. Why this matters: 1️⃣ The on-site facility produces high-quality, patient-specific stem cells, reducing costs and accelerating treatment timelines. 2️⃣ This model could make personalized cell therapies accessible to millions of patients. 3️⃣ The Foundry's first focus is on a novel Parkinson's therapy using patient-specific iPSCs. Cellino's AI-driven Nebula technology is set to transform traditional centralized manufacturing into a faster, cost-effective, and patient-centric model. This is exactly the kind of groundbreaking innovation we were excited to support during the Dash. Congratulations to the entire Cellino team! #ARPAHDash #Polyplexus #Cellino #iPSC #Biomanufacturing #Innovation #RegenerativeMedicine #Autologous